Novel lead generation through hypothetical pharmacophore three-dimensional database searching:: Discovery of isoflavonoids as nonsteroidal inhibitors of rat 5α-reductase

被引:36
作者
Chen, GS
Chang, CS
Kan, WM
Chang, CL
Wang, KC
Chern, JW
机构
[1] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan
关键词
D O I
10.1021/jm010433s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A hypothetical pharmacophore of 5 alpha -reductase inhibitors was generated and served as a template in virtual screening. When the pharmacophore was used, eight isoflavone derivatives were characterized as novel potential nonsteroidal inhibitors of rat 5 alpha -reductase. This investigation has demonstrated a practical approach toward the development of lead compounds through a hypothetic pharmacophore via three-dimensional database searching.
引用
收藏
页码:3759 / 3763
页数:5
相关论文
共 23 条
[1]  
ANDERSSON S, 1989, J BIOL CHEM, V264, P16249
[2]   4-AZA-3-OXO-5-ALPHA-ANDROST-1-ENE-17-BETA-N-ARYL-CARBOXAMIDES AS DUAL INHIBITORS OF HUMAN TYPE-1 AND TYPE-2 STEROID 5-ALPHA-REDUCTASES - DRAMATIC EFFECT OF N-ARYL SUBSTITUENTS ON TYPE-1 AND TYPE-2 5-ALPHA-REDUCTASE INHIBITORY POTENCY [J].
BAKSHI, RK ;
RASMUSSON, GH ;
PATEL, GF ;
MOSLEY, RT ;
CHANG, B ;
ELLSWORTH, K ;
HARRIS, GS ;
TOLMAN, RL .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3189-3192
[3]   MOLECULAR MODELING SOFTWARE AND METHODS FOR MEDICINAL CHEMISTRY .2. [J].
COHEN, NC ;
BLANEY, JM ;
HUMBLET, C ;
GUND, P ;
BARRY, DC .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (03) :883-894
[4]   INHIBITION OF 5-ALPHA-REDUCTASE IN GENITAL SKIN FIBROBLASTS AND PROSTATE TISSUE BY DIETARY LIGNANS AND ISOFLAVONOIDS [J].
EVANS, BAJ ;
GRIFFITHS, K ;
MORTON, MS .
JOURNAL OF ENDOCRINOLOGY, 1995, 147 (02) :295-302
[5]   STRUCTURE-ACTIVITY-RELATIONSHIPS FOR INHIBITION OF TYPE-1 AND TYPE-2 HUMAN 5-ALPHA-REDUCTASE AND HUMAN ADRENAL 3-BETA-HYDROXY-DELTA(5)-STEROID DEHYDROGENASE 3-KETO-DELTA(5)-STEROID ISOMERASE BY 6-AZAANDROST-4-EN-3-ONES - OPTIMIZATION OF THE C17 SUBSTITUENT [J].
FRYE, SV ;
HAFFNER, CD ;
MALONEY, PR ;
HINER, RN ;
DORSEY, GF ;
NOE, RA ;
UNWALLA, RJ ;
BATCHELOR, KW ;
BRAMSON, HN ;
STUART, JD ;
SCHWEIKER, SL ;
VANARNOLD, J ;
BICKETT, DM ;
MOSS, ML ;
TIAN, GC ;
LEE, FW ;
TIPPIN, TK ;
JAMES, MK ;
GRIZZLE, MK ;
LONG, JE ;
CROOM, DK .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2621-2627
[6]   19-nor-10-azasteroids, a new class of steroid 5 alpha-reductase inhibitors .2. X-ray structure, molecular modeling, conformational analysis of 19-nor-10-azasteroids and comparison with 4-azasteroids and 6-azasteroids [J].
Guarna, A ;
Occhiato, EG ;
Machetti, F ;
Marrucci, A ;
Danza, G ;
Serio, M ;
Paoli, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (21) :3466-3477
[7]  
HOLT KG, 1993, PHYS THER PRACT, V2, P1
[8]  
Igarashi S, 2000, CHEM PHARM BULL, V48, P382
[9]   Identification of novel farnesyl protein transferase inhibitors using three-dimensional database searching methods [J].
Kaminski, JJ ;
Rane, DF ;
Snow, ME ;
Weber, L ;
Rothofsky, ML ;
Anderson, SD ;
Lin, SL .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (25) :4103-4112
[10]   Pharmacological options in the treatment of benign prostatic hyperplasia [J].
Kenny, B ;
Ballard, S ;
Blagg, J ;
Fox, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) :1293-1315